Conditions
Column: ACE Excel 1.7 C18 Dimensions: 100 x 2.1 mm Part Number: EXL-171-1002U
Mobile Phase: A: 1 mM ammonium fluoride B: MeCN Flow Rate: 0.4 mL/min Injection: 1 µL Temperature: 40 °C Detection: AB SCIEX triple quad 5500 Negative ESI MRM Source temperature: 750 °C IonSpray voltage: -4500 V
Alcohol Biomarkers by UHPLC-MS/MS
Application #AN1910
1. Ethyl glucuronide (EtG)
Time (mins) %B
0.0 0 0.5 20 1.5 20 2.0 100 4.0 100 4.5 0
Transitions Quantifiers EtS 124.8 → 79.9 EtG 221 → 85 Qualifiers EtS 124.8 → 97 EtG 221 → 75
Reproduced with permission of Biotage GB Ltd, UK
1
2
Fluoride counter-ion thought to enhance negative ESI response
Detection limit ~ 1ng/ml in oral fluid
2. Ethyl sulphate (EtS)
Australia & New Zealand contact: [email protected] or call +61 7 3205 1209
Conditions
Column: ACE Excel 1.7 SuperC18 Dimensions: 50 x 3.0 mm Part Number: EXL-1711-0503U
Mobile Phase: A: 0.1% ammonia in H2O B: 0.1% ammonia in MeCN Flow Rate: 1 mL/min Injection: 0.7 µL Temperature: 20 °C Detection: UV, 230 nm
Fast Analysis of β-Blockers at High pH
Application #AN2160
Time (mins) %B
0.0 30 4.3 55 5.0 55 6.0 30
Post time 3 mins
min 1 2 3 4
mAU
0
20
40
60
80
100
120
140
160
1
4
5
6
7
2
3
1. Atenolol
3. Pindolol
7. Propranolol
4. Metoprolol
2. Acebutalol
6. Carvedilol
5. Oxprenolol
4 3 2 1 0 min
Australia & New Zealand contact: [email protected] or call +61 7 3205 1209
Conditions
Column: ACE Excel 1.7 C18-AR Dimensions: 100 x 2.1 mm Part Number: EXL-179-1002U
Mobile Phase: A: 2 mM ammonium acetate, 0.1% formic acid in H2O B: 2 mM ammonium acetate, 0.1% formic acid in MeOH Flow Rate: 0.4 mL/min Injection: 10 µL Temperature: 40 °C Detection: XEVO TQS triple quad MS Desolvation temperature: 500 °C Ion source temperature: 150 °C Positive mode ESI, MRM
Thyroid Hormones by LC-MS/MS (II)
Application #AN2180
1. T3 (Tri-iodothyronine)
3. rT3 (Reversed tri-iodothyronine)
2. T4 (Thyroxine)
Time (mins) %B
0.0 60 3.0 77 3.1 60
Reproduced with permission of Biotage GB Ltd, UK
1
3
2
TIC
Analyte Q1 (Da) Q3 (Da)
T3 651.8 605.8 (651.8) (507.8) (651.8) (478.9)
rT3 651.8 605.8 (651.8) (507.8) (651.8) (478.9)
T3/rT3-d6 I.S. 657.8 611.8 T4 777.7 731.7
(777.7) (351) (777.7) (633.8)
Australia & New Zealand contact: [email protected] or call +61 7 3205 1209
Conditions
Column: ACE Excel 1.7 C18 Dimensions: 100 x 2.1 mm Part Number: EXL-171-1002U
Mobile Phase: A: 5 mM ammonium acetate in H2O B: 5 mM ammonium acetate in MeOH Flow Rate: 0.3 mL/min Injection: 10 µL Temperature: 40 °C Detection: MS Quattro Premier XE triple quad MRM, positive and negative ESI mode Desolvation temperature: 450 °C Ion source temperature: 150 °C Collision gas pressure: 3.5 x 100-4 mbar
Drugs of Abuse Screen by
UHPLC-MS/MS
Application #AN2190
Page 1 of 2
Time (mins) %B
0.0 10 10.0 90 11.9 90 13.4 10 13.5 10
Reproduced with permission of Biotage GB Ltd, UK
Australia & New Zealand contact: [email protected] or call +61 7 3205 1209
Drugs Of Abuse Screen By
UHPLC-MS/MS
Application #AN2190
Page 2 of 2
Reproduced with permission of Biotage GB Ltd, UK
Peak Analyte Rt Q1 (Da) Q3 (Da) Peak Analyte Rt Q1 (Da) Q3 (Da)
1 Oxymorphone 2.62 302.2 198.1 27 Bromazepam 6.95 316.1 182.1 2 Morphine-d3 2.82 289.2 201.0 28 Ketamine 7.21 238.1 124.9 3 Morphine 2.95 286.2 201.0 29 Clonazepam 7.26 316.1 270.1 4 Hydromorphone 3.25 286.2 185.1 30 Nitrazepam 7.26 282.2 236.1 5 Amphetamine-d5 3.62 141.0 123.9 31 Alpha-hydroxytriazolam 7.34 359.1 331.1 6 Amphetamine 3.65 136.0 118.9 32 Flunitrazepam 7.34 314.2 268.2 7 Dihydrocodeine 3.66 302.2 199.1 33 Alpha-hydroxyalprazolam 7.54 325.2 297.1 8 MDA 3.67 180.1 105.0 34 Estazolam 7.56 295.2 267.2 9 MDMA 3.75 194.1 163.0 35 Zolpidem 7.73 308.2 235.1
10 Methamphetamine 3.8 150.0 90.9 36 Triazolam 7.77 343.0 308.1 11 Oxycodone 4.03 316.2 241.2 37 2-Hydroxyethylflurazepam 7.77 333.2 109.0 12 MDEA 4.12 208.2 163.0 38 Lorazepam 7.80 321.1 275.1 13 BZE-d3 4.15 293.1 171.0 39 Oxazepam 7.82 287.2 241.0 14 BZE 4.17 290.1 168.0 40 Alprazolam 7.85 309.2 281.2 15 6-MAM 4.48 328.2 165.1 41 Methadone 7.99 310.2 265.2 16 Codeine 4.59 300.3 215.1 42 Temazepam 8.05 301.1 255.1 17 Norfentanyl 4.71 233.1 84.0 43 Nordiazepam 8.44 271.1 139.9 18 7-Amino-clonazepam 4.77 286.2 121.0 44 Midazolam 8.61 326.2 291.2 19 Hydrocodone 4.94 300.2 199.1 45 Diazepam-d5 8.63 290.2 154.0 20 7-Amino-flunitrazepam 5.34 284.2 135.0 46 Diazepam 8.67 285.2 154.0 21 Cocaine 5.99 304.2 182.0 47 Flurazepam 8.68 388.2 315.1 22 Norbuprenorphine 6.47 414.3 101.0 48 Fentanyl 8.85 337.3 105.0 23 PCP 6.49 244.2 159.9 49 THC-COOH-d3 9.98 348.2 302.2 24 Zaleplon 6.55 306.2 264.2 50 THC-COOH 10.01 345.2 299.2 25 EDDP 6.58 278.2 234.2 51 Buprenorphine 11.70 468.3 101.0 26 Norketamine 6.9 224.1 124.9
Australia & New Zealand contact: [email protected] or call +61 7 3205 1209
Conditions
Column: ACE 3 C18-Amide ACE Excel 1.7 C18-Amide Dimensions: 250 x 2.1 mm 50 x 3.0 mm Part Number: 250 x 2.1 mm (EXL-1112-2502U), 50 x 3 mm (EXL-1712-0503U) Mobile Phase: 20 mM H3PO4 in MeOH/H2O (40:60 v/v) Flow Rate: 0.21 mL/min (250 x 2.1 mm) 0.8 mL/min (50 x 3.0 mm) Injection: 5 µL (250 x 2.1 mm) 2 µL (50 x 3.0 mm) Temperature: 20 °C Detection: UV, 210 nm
Fast Separation of Organic Acids
Application #AN2200
min 5 10 15 20 25 30 35 40
mAU
0
25
50
75
100
125
150
175
200
1
2
3
4
5
mAU
0
25
50
75
100
125
150
175
1
2
3
4
5
min 5 10 15 20 25 30 35 40
4. Cinnamic acid
1. Sinapic acid
3. 3,4-Dimethoxycinnamic acid
2. Ferulic acid
5. 4-Methoxycinnamic acid
ACE 3 C18-Amide
ACE Excel 1.7 C18-Amide
0 I
0 I
Australia & New Zealand contact: [email protected] or call +61 7 3205 1209
Conditions
Column: ACE Excel 1.7 C18 Dimensions: 50 x 3.0 mm Part Number: EXL-171-0503U
Mobile Phase: A: 10 mM ammonium acetate pH 6.0 in H2O B: 10 mM ammonium acetate pH 6.0 in MeOH/H2O (90:10 v/v) Flow Rate: 0.51 mL/min Injection: 0.7 µL (50 x 3.0 mm) Temperature: 40 °C Detection: UV, 230 nm
Fast Analysis of Paracetamol and
Related Substances (I)
Application #AN2210
1. 4-Aminophenol 2. Hydroquinone 3. Paracetamol 4. 2-Acetamidophenol 5. Phenol 6. 4-Nitrophenol 7. 2-Nitrophenol 8. 4-Chloroacetanilide
Time (mins) %B
0.00 5 0.08 5 5.08 95 6.76 95 7.09 5 10.00 5
For enhanced resolution of paracetamol and related compounds, see AN2220.
0 2 4 6
mAU
0
20
40
60
80
100
1
2
3
4
5
7 6
8
2 4 6 min 0
Australia & New Zealand contact: [email protected] or call +61 7 3205 1209
Conditions
Column: ACE Excel 1.7 C18 Dimensions: 100 x 3.0 mm Part Number: EXL-171-1003U Mobile Phase: A: 10 mM ammonium acetate pH 6.0 in H2O B: 10 mM ammonium acetate pH 6.0 in MeOH/H2O (90:10 v/v) Flow Rate: 0.51 mL/min Injection: 1.4 µL Temperature: 40 °C Detection: UV, 230 nm
Enhanced Resolution of Paracetamol
and Related Substances
Application #AN2220
Time (mins) %B
0.00 5 0.21 5 10.23 95 13.56 95 14.16 5 20.24 5
1. 4-Aminophenol 2. Hydroquinone 3. Paracetamol 4. 2-Acetamidophenol 5. Phenol 6. 4-Nitrophenol 7. 2-Nitrophenol 8. 4-Chloroacetanilide
For enhanced speed of paracetamol and related compounds, see AN2210.
0 2.5 5 7.5 10 12.5
mAU
0
20
40
60
80
100
1
2
3
4
5
7 6
8
2.5 5 7.5 10 12.5 min 0
Australia & New Zealand contact: [email protected] or call +61 7 3205 1209
Conditions
Column: ACE Excel 1.7 C18-Amide Dimensions: 50 x 3.0 mm Part Number: EXL-1712-0503U
Mobile Phase: A: 0.1% formic acid in H2O B: 0.1% formic acid in MeCN Flow Rate: 1.3 mL/min Injection: 1 µL Temperature: 45 °C Detection: UV, 260 nm
Fast Separation of Vanillin Compounds
Application #AN2240
4. 4-Hydroxybenzaldehyde
1. Vanillic acid
3. Vanillin
2. 4-Hydroxybenzoic acid
Time (mins) %B
0.00 25 1.32 75 1.49 75 1.60 25
min 0.2 0.4 0.6 0.8 1 1.2 1.4
mAU
0
50
100
150
200
250
1
2
3
4
5
6
7
8
7. Ethyl vanillin
6. o-Vanillin
5. Guaicol
8. Eugenol
0
Australia & New Zealand contact: [email protected] or call +61 7 3205 1209
Conditions
Column: ACE Excel 1.7 C18 Dimensions: 100 x 2.1 mm Part Number: EXL-171-1002U
Mobile Phase: A: 2 mM ammonium acetate, 0.1% formic acid/MeCN (90:10 v/v) B: 2 mM ammonium acetate, 0.1% formic acid in MeCN (10:90 v/v) Flow Rate: 0.5 mL/min Injection: 10 µL Temperature: 40 °C Detection: AB SCIEX triple quad 5500 Negative ESI MRM Source temperature: 450 °C IonSpray voltage: -2400 V
Perfluorinated Compounds in Water by
LC-MS/MS
Application #AN2260
Reproduced with permission of Biotage GB Ltd, UK. For extraction conditions see Biotage Application Note AN839
XIC of -MRM (9 pairs): Exp 1, 212.900/168.900 amu Expected RT: 1.0 ID: HFBA 1 from Sample 5 (PFA8 5ng/mL) of 150224_standards.wiff (... Max. 3.8e4 cps.
0.5 1.0 1.5 2.0 2.5 3.0 3.5 4.0 4.5Time, min
0.0
5.0e4
1.0e5
1.5e5
2.0e5
2.5e5
3.0e5
3.5e5
4.0e5
4.5e5
5.0e5
5.5e5
6.0e5
6.5e5
7.0e5
7.5e5
8.0e5
8.5e5
Inte
nsity
, cps
0.86
0.99 1.20 1.250.76
1
2
3
4
5
6
7
Transitions 1. Perfluorohexanoic acid (m/z 313.0 → 268.9) 2. Perfluorobutanesulfonic acid (m/z 299.0 → 79.9) 3. Perfluorooctanoic acid (m/z 413.0 → 368.9) 4. Perfluorohexanesulfonic acid (m/z 399.0 → 80.0) 5. Perfluorononanoic acid (m/z 463.0 → 419.0) 6. Perfluorodecanoic acid (m/z 513.0 → 469.0) 7. Perfluorooctanesulfonic acid (m/z 499.0 → 80.0)
Time (mins) %B
0.0 25 0.5 25 3.5 70 4.0 100 5.5 100 6.0 25 9.0 25
4.0 3.0 2.5 2.0 3.5 0.5 0 1.5 1.0 4.5 Time, mins
Australia & New Zealand contact: [email protected] or call +61 7 3205 1209
Conditions
Column: ACE Excel 1.7 C18-PFP Dimensions: 2 x 100 x 3.0 mm (coupled) Part Number: 2 x EXL-1710-1003U
Mobile Phase: A: 0.1% formic acid in H2O B: 0.1% formic acid in MeCN Flow Rate: 0.8 mL/min Injection: 2 µL Temperature: 80 °C Detection: UV, 254 nm
Ultra Resolution Separation of the
Natural Product Ginkgo Biloba
Application #AN2270
1. Ginkgo Biloba
Time (mins) %B
0.0 5 0.72 5 15.72 50 18.72 100 20.72 100 22.72 5
min 2 4 6 8 10 12
mAU
-5
0
5
10
15
20
25
30
Australia & New Zealand contact: [email protected] or call +61 7 3205 1209
Conditions
Column: ACE Excel 1.7 CN-ES Dimensions: 50 x 3.0 mm Part Number: EXL-1713-0503U
Mobile Phase: A: 0.1% formic acid in H2O B: 0.1% formic acid in MeCN Flow Rate: 0.7 mL/min Injection: 0.5 µL Temperature: 30 °C Detection: UV, 240 nm
Separation of Aspirin and Related
Substances
Application #AN2280
1. 2-Acetamidophenol 2. 4-Hydroxyisophthalic acid 3. Acetanilide 4. Salicylamide 5. Aspirin 6. Phenacetin 7. Salicylic acid 8. Acetylsalicylsalicylic acid 9. Salsalate
Time (mins) %B
0 5 5 90 6 90
6.5 5
min 1 2 3 4
4
5
6
7
8
9
2
3
1
2 1 4 min 3